Mol. Cancer Ther.

ISSN	1538-8514
ISSN-L	1535-7163
IUID	269d08937b404031877416e1a77805c1
Modified	2020-11-27T13:12:55.290Z
Created	2018-12-05T09:28:47.417Z

Year 2025

PubMed DOI Crossref

Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts.

Lundgren Mortensen AC, Berglund H, Jha P, ..., Frejd FY, Nestor M

Mol. Cancer Ther. 24 (5) 753-762 [2025-05-02; online 2025-02-20]

Year 2024

DOI Crossref

Abstract PR002: Hypoxia-induced epigenetic changes coordinate transcription start site selection and translational control through remodeling of 5’UTRs

Watt K, Dauber B, Szkop KJ, ..., Larsson O, Postovit LM

Mol. Cancer Ther. 23 (11_Supplement) PR002-PR002 [2024-11-14; online 2024-11-14]

Year 2022

PubMed DOI Crossref

Inhibition of Oxidized Nucleotide Sanitation By TH1579 and Conventional Chemotherapy Cooperatively Enhance Oxidative DNA Damage and Survival in AML.

Centio A, Estruch M, Reckzeh K, ..., Helleday T, Theilgaard-Mönch K

Mol. Cancer Ther. 21 (5) 703-714 [2022-05-04; online 2022-03-06]

Year 2018

PubMed DOI Crossref

Leukocyte Differentiation by Histidine-Rich Glycoprotein/Stanniocalcin-2 Complex Regulates Murine Glioma Growth through Modulation of Antitumor Immunity.

Roche FP, Pietilä I, Kaito H, ..., Welsh M, Claesson-Welsh L

Mol. Cancer Ther. 17 (9) 1961-1972 [2018-09-00; online 2018-06-26]

Year 2017

PubMed DOI Crossref

Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In Vivo Tumor Growth.

Spyrou A, Kundu S, Haseeb L, ..., Vlodavsky I, Forsberg-Nilsson K

Mol. Cancer Ther. 16 (8) 1705-1716 [2017-08-00; online 2017-07-17]

PubMed DOI Crossref

Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.

Borgatti A, Koopmeiners JS, Sarver AL, ..., Modiano JF, Vallera DA

Mol. Cancer Ther. 16 (5) 956-965 [2017-05-00; online 2017-02-13]

Year 2016

PubMed DOI Crossref

The Tyrosine Kinase Inhibitor Imatinib Augments Extracellular Fluid Exchange and Reduces Average Collagen Fibril Diameter in Experimental Carcinoma.

Olsson PO, Gustafsson R, In 't Zandt R, ..., Rubin K, Kalamajski S

Mol. Cancer Ther. 15 (10) 2455-2464 [2016-10-00; online 2016-07-29]

Affiliated researcher

PubMed DOI Crossref

Antagonists of IGF:Vitronectin Interactions Inhibit IGF-I-Induced Breast Cancer Cell Functions.

Kashyap AS, Shooter GK, Shokoohmand A, ..., Upton Z, Hollier BG

Mol. Cancer Ther. 15 (7) 1602-1613 [2016-07-00; online 2016-05-09]

Year 2015

PubMed DOI Crossref

The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responses.

Christiansson L, Söderlund S, Mangsbo S, ..., Loskog A, Olsson-Strömberg U

Mol. Cancer Ther. 14 (5) 1181-1191 [2015-05-00; online 2015-03-11]

Year 2014

PubMed DOI Crossref

Marine sponge Cribrochalina vasculum compounds activate intrinsic apoptotic signaling and inhibit growth factor signaling cascades in non-small cell lung carcinoma.

Zovko A, Viktorsson K, Hååg P, ..., Carmeli S, Lewensohn R

Mol. Cancer Ther. 13 (12) 2941-2954 [2014-12-00; online 2014-10-15]

PubMed DOI Crossref

BRCA2 and RAD51 promote double-strand break formation and cell death in response to gemcitabine.

Jones RM, Kotsantis P, Stewart GS, Groth P, Petermann E

Mol. Cancer Ther. 13 (10) 2412-2421 [2014-10-00; online 2014-07-22]

PubMed DOI Crossref

A pragmatic definition of therapeutic synergy suitable for clinically relevant in vitro multicompound analyses.

Kashif M, Andersson C, Åberg M, ..., Larsson R, Gustafsson MG

Mol. Cancer Ther. 13 (7) 1964-1976 [2014-07-00; online 2014-04-22]